In a 45-year-old man with a prior ischemic stroke and residual right‑sided deficits, no known hypertension, diabetes, or thyroid disease, what pharmacologic regimen should be initiated for secondary stroke prevention?

Start Antiplatelet Therapy Immediately with Clopidogrel 75 mg Daily or Aspirin 81-325 mg Daily

For this 45-year-old man with prior ischemic stroke (not in the acute phase), you should initiate long-term single antiplatelet therapy with either clopidogrel 75 mg daily OR aspirin 81-325 mg daily as the cornerstone of secondary stroke prevention. 1 Given that he was never started on any medications post-stroke, this is the most critical intervention to prevent recurrent stroke.

Antiplatelet Therapy Selection

The 2023 World Stroke Organization guidelines clearly state that for patients with non-cardioembolic ischemic stroke who do not require anticoagulation, acceptable options include:

• Aspirin 81-325 mg daily
• Clopidogrel 75 mg daily
• Aspirin 25 mg + extended-release dipyridamole 200 mg twice daily

1

I recommend starting with clopidogrel 75 mg daily as it has comparable or slightly superior efficacy to aspirin with potentially lower gastrointestinal bleeding risk 2, and requires only once-daily dosing which may improve adherence in this patient who has not been on any medications.

Important Caveats:

• Dual antiplatelet therapy (aspirin + clopidogrel) is NOT indicated for long-term secondary prevention beyond 21-30 days and is only used in the acute setting for minor stroke (NIHSS ≤3-5) or high-risk TIA 1. Since his stroke occurred in the past (not acute), he does not qualify for dual therapy.
• If aspirin is chosen, 81 mg daily is preferred over higher doses as it provides similar efficacy with lower bleeding risk
• The combination aspirin/dipyridamole is effective but has higher discontinuation rates due to headache 2, 3

Add High-Intensity Statin Therapy

Start atorvastatin 80 mg daily regardless of his baseline lipid levels. 3 The SPARCL trial demonstrated that high-dose atorvastatin reduces recurrent stroke risk in patients with prior stroke or TIA, even in those without known coronary disease. This represents a 16% relative risk reduction in stroke recurrence 3.

• Do NOT wait for lipid panel results to initiate statin therapy
• High-intensity statin therapy is indicated for secondary stroke prevention independent of LDL levels
• Check baseline lipids and liver function, but start therapy immediately

Initiate Blood Pressure Management

All post-stroke patients should receive blood pressure lowering therapy unless contraindicated by symptomatic hypotension. 4, 5 Even if he doesn't have documented hypertension, blood pressure reduction is beneficial for secondary stroke prevention.

Target blood pressure: <140/90 mmHg (or <130/80 mmHg if tolerated) 1, 6

First-line agents include:

• ACE inhibitors or ARBs
• Thiazide diuretics
• Calcium channel blockers

4, 5

Start with an ACE inhibitor (e.g., lisinopril 10 mg daily) or ARB if ACE inhibitor not tolerated, as these have the most robust evidence for stroke prevention and address blood pressure variability 5.

Critical Next Steps - Labs and Workup

Before finalizing the regimen, you need:

1. Lipid panel (LDL, HDL, triglycerides) - but start statin regardless
2. Hemoglobin A1c and fasting glucose - to screen for diabetes given his stroke history
3. Basic metabolic panel - baseline renal function before ACE inhibitor
4. Complete blood count - baseline before antiplatelet therapy
5. Liver function tests - baseline before statin
6. TSH - hypothyroidism may influence stroke risk 7, 8
7. ECG and consider prolonged cardiac monitoring - to rule out atrial fibrillation, which would change management to anticoagulation 6, 5
8. Carotid ultrasound - to assess for significant stenosis that might require intervention 9, 6
9. Brain imaging (MRI preferred) - if not done recently, to characterize stroke pattern and rule out other pathology

Address Modifiable Risk Factors Aggressively

Smoking cessation is mandatory - even 1 cigarette daily increases stroke risk significantly. Offer:

• Nicotine replacement therapy
• Varenicline or bupropion
• Behavioral counseling

6, 5

Marijuana use - counsel on cessation as cannabis use may increase stroke risk through multiple mechanisms

Alcohol use - current consumption (6 beers/month) is modest, but counsel on limiting to ≤2 drinks per day for men

Common Pitfalls to Avoid

1. Do NOT combine antiplatelet therapy with anticoagulation unless there is a specific indication (e.g., mechanical heart valve + stroke) - this dramatically increases bleeding risk 10, 2

2. Do NOT use dual antiplatelet therapy long-term - the MATCH and CHARISMA trials showed increased bleeding without clear benefit beyond the acute period 10, 2

3. Do NOT delay statin therapy waiting for "abnormal" lipid levels - the benefit is independent of baseline cholesterol 3

4. Do NOT assume the stroke mechanism - you must rule out cardioembolic sources (especially atrial fibrillation) as this would require anticoagulation instead of antiplatelet therapy 6, 5

5. Do NOT forget that he has residual deficits - ensure he has access to rehabilitation services and assess for depression, which is common post-stroke and affects medication adherence

If Atrial Fibrillation is Discovered

If prolonged cardiac monitoring reveals atrial fibrillation, switch from antiplatelet therapy to anticoagulation with a direct oral anticoagulant (DOAC) such as:

• Apixaban 5 mg twice daily
• Rivaroxaban 20 mg daily
• Dabigatran 150 mg twice daily

6, 5

DOACs are preferred over warfarin for stroke prevention in atrial fibrillation due to superior safety profile and no need for INR monitoring.

Summary of Immediate Prescriptions

Start today:

1. Clopidogrel 75 mg once daily (or aspirin 81 mg if clopidogrel unavailable/unaffordable)
2. Atorvastatin 80 mg once daily
3. Lisinopril 10 mg once daily (titrate based on blood pressure response)
4. Nicotine replacement therapy for smoking cessation

Order labs and cardiac monitoring to refine the diagnosis and ensure no contraindications to this regimen exist.